Related Experiment Video
Updated: Aug 30, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu1, Jiangyao Duan2, Na Yang3
1State Key Laboratory of Biotherapy and Cancer Center West China Hospital Sichuan University; Collaborative Innovation Center for Biotherapy Chengdu China.
Abstract:
Messenger ribonucleic acid (mRNA) vaccines made their successful public debut in the effort against the COVID-19 outbreak starting in late 2019, although the history of mRNA vaccines can be traced back decades. This review provides an overview to discuss the historical course and present situation of mRNA vaccine development in addition to some basic concepts that underly mRNA vaccines. We discuss the general preparation and manufacturing of mRNA vaccines and also discuss the scientific advances in the in vivo delivery system and evaluate popular approaches (i.e., lipid nanoparticle and protamine) in detail. Next, we highlight the clinical value of mRNA vaccines as potent candidates for therapeutic treatment and discuss clinical progress in the treatment of cancer and coronavirus disease 2019. Data suggest that mRNA vaccines, with several prominent advantages, have achieved encouraging results and increasing attention due to tremendous potential in disease management. Finally, we suggest some potential directions worthy of further investigation and optimization. In addition to basic research, studies that help to facilitate storage and transportation will be indispensable for practical applications.
Insights
Messenger RNA (mRNA) vaccines have advanced significantly, showing great potential for treating diseases like cancer and COVID-19. Further research into delivery systems and logistics is crucial for their widespread application.
Area of Science:
- Vaccinology
- Molecular Biology
- Biotechnology
Background:
- Messenger ribonucleic acid (mRNA) vaccine technology has a history spanning decades, with recent success against COVID-19.
- mRNA vaccines represent a rapidly advancing field with significant therapeutic potential.
Purpose of the Study:
- To review the historical development and current status of mRNA vaccine technology.
- To discuss the fundamental concepts, manufacturing processes, and delivery systems for mRNA vaccines.
- To evaluate the clinical applications and future directions of mRNA vaccine research.
Main Methods:
- Literature review of historical data and current research on mRNA vaccines.
- Analysis of scientific advances in in vivo delivery systems, including lipid nanoparticles and protamine.
- Evaluation of clinical trial progress for mRNA vaccines in cancer and infectious diseases.
Main Results:
- mRNA vaccines have demonstrated encouraging results and garnered significant attention due to their advantages.
- Lipid nanoparticles and protamine are key delivery systems being optimized for in vivo applications.
- Clinical progress shows mRNA vaccines are potent candidates for therapeutic treatments, particularly for cancer and COVID-19.
Conclusions:
- mRNA vaccines possess numerous advantages and show tremendous potential for disease management.
- Further research is needed to optimize delivery systems, manufacturing, and logistical aspects like storage and transportation.
- Continued investigation into mRNA technology is essential for its practical application and broader impact on public health.
More Related Videos
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Vaccinations
Preventive Healthcare Services
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...